NDAINJECTIONINJECTABLEPriority Review
Approved
Mar 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug Shortage Active
HEPATOLITE is currently in shortage. Reason: Unavailable. This may impact manufacturing, supply chain, and quality hiring at the manufacturer.
Drug data last refreshed 17h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HEPATOLITE is a technetium TC-99m labeled radiopharmaceutical diagnostic agent used for hepatobiliary imaging to assess liver function and biliary tract patency. It is administered via intravenous injection and localizes in the liver and biliary system, enabling visualization of hepatic uptake and excretion. This imaging agent helps clinicians diagnose cholecystitis, biliary obstruction, and hepatic dysfunction.
LOE Approaching
Product approaching loss of exclusivity with low linked job openings suggests a mature, stable team managing a legacy diagnostic franchise with limited growth opportunities.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on HEPATOLITE offers limited growth trajectory with zero linked job openings, reflecting a mature diagnostic product in decline. Career value lies in managing a legacy franchise through LOE, optimizing operations, and navigating supply chain challenges rather than driving innovation.
Product ManagerRegulatory Affairs Specialist
Worked on HEPATOLITE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.